Stocks · Health care · Pharmaceutical Preparations

ROCKET PHARMACEUTICALS, INC.

RCKT Clue Score36
United States Fiscal year ends December CIK 0001281895 Results filed 10 Aug 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Gaurav Shah
21 May 2026
CEO
Sold after exercise
55,684
$3.09
$171.84K
David P Southwell
15 Apr 2024
Director
Sold after exercise
10,000
$24.05
$240.52K
David P Southwell
12 Apr 2024
Director
Sold after exercise
10,284
$25.16
$258.70K
David P Southwell
12 Apr 2024
Director
Sold after exercise
59,716
$24.22
$1.45M
John Militello
29 Feb 2024
See Remarks
Sold after exercise
10,000
$29.85
$298.45K

What was left out

Form 4 filings counted 306
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 18
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 17,342,953
Sales filed before the plan box existed 17
History held since 25 Feb 2015